Brief: Karyopharm Therapeutics Q4 Net Income USD -41.837 Million
29/02/2024 12:30
Feb 29 (Reuters) - Karyopharm Therapeutics Q4 operating expenses USD 71.555 million. * Q4 operating income USD -37.808 million * outlook FY revenue USD 140-160 million
KPTIQ — Karyopharm Therapeutics News Story
0.000.00%
Last trade - 00:00- $0.39m
- $257.57m
- $146.07m